OpenAI Launches New AI Model for Life Science Research
OpenAI officially released GPT-Rosalind, a dedicated large model tailored for biomedicine and life science research. Trained with massive medical papers, genetic data and chemical experiment resources, it assists in new drug development, pathological research, academic sorting and experimental planning. It is now in beta testing with global pharmaceutical enterprises and research institutes, filling the technical gap in high-end medical research and boosting integrated development of biotech and AI.
#GPTRosalind #LifeScienceAI #DrugDiscovery #OpenAI
Previous article
new
Google Gemma 4 Fully Open-Sourced to Promote AI Popularization
Humanoid Robot Breaks Half-Marathon World Record
OpenAI Launches New AI Model for Life Science Research
Stanford AI Index 2026: Global Investment Hits Record High
LinkedIn Report: 1.3M New AI Jobs Amid Hiring Slowdown
GitHub Trending: "Nuwa Skill" Distills Celebrity Thinking Patterns
Anthropic Valuation Soars to $800B: Challenging Adobe & Figma
Zuck Moves Desk to AI Team: Coding All Day Long
OpenAI GPT-5.4 Launches Deep Research, Boosting Scientific Analysis
Tesla AI5 Chip Tapes Out, 40x Faster Than AI4, Matches NVIDIA Blackwell